Jerusalem, Israel

Shimon Slavin

USPTO Granted Patents = 24 


 

Average Co-Inventor Count = 2.5

ph-index = 9

Forward Citations = 251(Granted Patents)


Location History:

  • Tel Aviv, IL (2015 - 2016)
  • Jerusalem, IL (1995 - 2017)

Company Filing History:


Years Active: 1995-2017

Loading Chart...
Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents

Title: Shimon Slavin: Innovator in Telomerase Research

Introduction

Shimon Slavin, based in Jerusalem, IL, is a prolific inventor with a remarkable portfolio of 24 patents. His work primarily focuses on innovations in the field of medical research, particularly concerning telomerase and its implications for treating various diseases and disorders.

Latest Patents

Among his latest inventions are "Telomerase activating compounds and methods of use thereof," which addresses the activation of telomerase using specific compounds to treat related conditions. Another significant contribution is the "Tri-aryl compounds and compositions comprising the same," which presents a novel class of tri-aryl compounds along with processes for their preparation. These patents exemplify his commitment to advancing medical science.

Career Highlights

Shimon has worked with Hadasit Medical Research Services and Development Ltd. as well as Hadasit Medical Research Services and Development Company. Through his efforts in these organizations, he has made significant contributions to medical research, focusing on the innovative applications of his patented compounds.

Collaborations

Throughout his career, Shimon Slavin has collaborated with prominent figures in the field, including Arnon Nagler and Mark Pines. These collaborations have undoubtedly enhanced his research capabilities and contributed to his successful inventions.

Conclusion

In summary, Shimon Slavin stands out as an influential inventor whose work in telomerase research has the potential to impact medical treatment significantly. His extensive patent portfolio and collaborations demonstrate his dedication to innovation and improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…